Install
Drug Discovery & Trials
Targets, biomarkers, AI discovery, and Phases I–III clinical results.
- 19 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Drug Discovery & Trials
ATMP in Belgium: Building a Stronger Life Sciences Ecosystem | Deloitte Belgium
12+ hour, 52+ min ago (148+ words) Written with contributions from BioWin, this report examines where Belgium has a credible opportunity to lead and what is needed to translate scientific promise into successful delivery. Advanced therapies continue to progress across Europe, supported by scientific innovation and regulatory…...
Una startup biotech serba ripercorre il proprio viaggio da Belgrado a Cambridge con un documentario sulla scienza della longevità
8+ hour, 2+ min ago (180+ words) Eagle-Tribune Una startup biotech serba ripercorre il proprio viaggio da Belgrado a Cambridge con un documentario sulla scienza della longevità Cambridge Tech Week 2026 BELGRADO, Serbia--(BUSINESS WIRE)--set 21, 2026-- BioEridan, biotech serba supportata dal fondo TS Ventures di Telekom Srbija, ha…...
New Shift in This Round of Innovative Drug Market Rally: "Wet Experiments" Emerge as Core Assets in the AI Drug Discovery Era
3+ hour, 26+ min ago (1429+ words) In June, Anthropic launched Claude Science, built its own physical wet lab, and spent 400 million USD to acquire Coefficient Bio, an AI drug R&D startup founded only eight months prior. A company that built its reputation on models went…...
Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug
20+ hour, 27+ min ago (339+ words) Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop. "What…...
Serbian Biotech Startup Takes Its Journey from Belgrade to Cambridge with Documentary on Longevity Science
16+ hour, 12+ min ago (365+ words) BioEridan, a Serbian biotechnology startup backed by Telekom Srbija Group’s TS Ventures Fund, has premiered a new documentary showcasing its development of underwater Aquafarms and its ambition to contribute to the next generation of longevity science. BioEridan: Science Beneath the…...
Novo Nordisk and Anthropic Announce Collaboration to Advance Drug Discovery With Claude
5+ hour, 58+ min ago (404+ words) BioBuzz Novo Nordisk and Anthropic Announce Collaboration to Advance Drug Discovery With Claude Novo Nordisk and Anthropic announced a collaboration on September 16, 2026 aimed at helping Novo accelerate the development of new medicines and advance AI-driven software development. The companies will…...
AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery
10+ hour, 22+ min ago (360+ words) Iambic Therapeutics − Multi-year partnership applies Iambic’s AI platform to speed up small molecule drug discovery in immunology, neuroscience and oncology “Combining Iambic's platform with the drug hunting expertise of AbbVie scientists can help us make more precise decisions about the…...
Plant Compound Calein C Blocks Key Bacterial Antioxidant Enzyme, Study
1+ hour, 12+ min ago (625+ words) A small molecule extracted from a Brazilian wildflower has emerged as a surprising new weapon in the fight against antibiotic resistance....
Breaking: FDA Takes Crucial Step To Accelerate Use Of Alternatives To Animal Testing
5+ hour, 30+ min ago (787+ words) Today is one of the most impactful days ever in our quest to reduce animal testing in drug development and to replace an old, tired, broken system that relied on tormenting dogs, primates, and other animals with 21st-century methods grounded…...
A new spin on spinouts? Cambridge’s model for medtech innovation (via Passle)
11+ hour, 54+ min ago (305+ words) An overview of the OSA, covering its scope, key obligations and what organisations need to navigate the evolving regulatory landscape. We advise companies in the women's health sector on the commercial, legal and regulatory challenges of bringing new therapies and…...